Find policies, billing codes, payers, states, and providers
Intradiscal Procedures
Customize your policy alerts
Sign up for univerahealthcare Policy 7.01.112 alerts
Get alerted when Policy 7.01.112 changes without checking for updates manually.
Monitor payer policy activity
Defines Univera Healthcare's coverage stance for intradiscal procedures used to treat spinal disc pathology; applies to medical necessity determinations for members subject to this payer's policies.
No material clinical or coverage changes in this revision.
Coverage Criteria — Intradiscal Procedures
Investigational Intradiscal Procedures
Intradiscal procedures are considered investigational including, but not limited to, the following:
Enumerated as investigational per policy.
Procedures described and evidence summary
Descriptions of procedures and intended purposes (informational; coverage decisions depend on evidence and policy cross-references):
Informational descriptions from policy.
Evidence summaries and coverage-relevant findings
Summary of evidence and guideline recommendations for various intradiscal procedures
Based on trial recruitment and outcomes reported in policy.
Trial limitations noted in policy.
Policy cites trials, systematic reviews, and guideline assessments.
Policy reports primary outcome benefit with limited confirmatory data.
Policy describes VAST interim findings.
Policy recommends longer, higher-quality trials.
Intradiscal injections are explicitly listed among procedures considered investigational. Examples named in the policy include injectates such as methylene blue, hyaluronate, ozone/oxygen-ozone, bone marrow concentrates, chymopapain, platelet-rich plasma (PRP), mesenchymal stem cells, glucocorticoids, hyaluronidase, and growth factors.
Automated percutaneous discectomy (APD) is described in the evidence summary as having limited and conflicting randomized trial data. A Cochrane review concluded APD produced poorer outcomes than standard discectomy in some trials, and a randomized LAPDOG trial was underpowered (planned n=330; enrolled 36) with similar six‑month success rates reported among the small evaluable cohort, leading authors to note a lack of scientific support for its effectiveness.
Multiple CPT and HCPCS entries are explicitly designated (E/I) Experimental/Investigational in the policy and are treated accordingly for routine coverage determinations. Examples include CPT codes for intradiscal electrothermal annuloplasty (22526, 22527), percutaneous decompression and related codes (e.g., 62287, 62330/62331, 0274T/0275T), codes for percutaneous injection of allogeneic cellular/tissue products (0627T–0630T), and HCPCS codes such as C2614, G0276, and S2348.
Coverage of intradiscal services is contract‑dependent. If a particular Univera product does not include a service in its benefit design, the medical policy criteria do not apply; conversely, when a product covers the service and no higher‑priority Medicare/Medicaid rule exists, the policy criteria govern coverage determinations.
Overall, the policy designates intradiscal procedures as investigational and therefore not supported as medically necessary under the policy statements. The investigational designation encompasses a broad list of intradiscal techniques, including injectate‑based therapies and device‑based decompression/thermal procedures.
Randomized trials and systematic reviews for several intradiscal techniques (including APD, IDET/IDTA, PIRFT and similar procedures) show limited, conflicting, or insufficient evidence of efficacy. For APD specifically, small or halted RCTs and Cochrane review findings raise concerns about inferiority to standard discectomy. For IDET/IDTA and PIRFT, systematic reviews and randomized studies did not demonstrate consistent benefit and noted potential for serious complications, supporting the policy’s position that routine use is not supported by current evidence.
Systematic reviews and randomized studies evaluating intradiscal electrothermal annuloplasty (IDET/IDTA) and percutaneous intradiscal thermocoagulation (PIRFT) have not demonstrated clear efficacy. The policy cites a Cochrane‑style review and guideline assessments concluding that available evidence does not support effectiveness and that these procedures are associated with potentially serious adverse events.
Coding — Procedure and Diagnosis Codes
| No codes listed |
| Stryker DeKompressor | Device example for automated percutaneous discectomy |
| Nucleotome | Device example for automated percutaneous discectomy |
| SpineJet Hydrodiscectomy System | HydroCision device example for hydrodiscectomy |
| No codes listed |
| 62287 | Decompression, percutaneous, of nucleus pulposus of intervertebral disc, any method, utilizing needle-based technique to remove disc material under fluoroscopic imaging or other form of indirect visualization, with discography. |
| 62330 | Decompression, percutaneous, with partial removal of the ligamentum flavum, including laminotomy for access, epidurography, and imaging guidance, bilateral; one interspace, lumbar. (Effective 01/01/26; replaces 0275T). |
| 62331 | Decompression, percutaneous, of neural elements (with or without ligamentous resection, discectomy, facetectomy and/or foraminotomy), any method, under indirect image guidance, single or multiple levels, unilateral or bilateral; lumbar. (E/I) Effective 01/01/26. |
| 0275T | Percutaneous laminotomy/laminectomy (interlaminar approach) for decompression including laminotomy for access, epidurography, and imaging guidance, bilateral; additional interspace(s), lumbar. (Termed 12/31/2025). |
| 0274T | Percutaneous laminotomy/laminectomy (interlaminar approach) for decompression of neural elements under indirect image guidance. |
| 0627T | Percutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, unilateral or bilateral injection, with fluoroscopic guidance, cervical or thoracic; single or multiple levels. |
| 0628T | Percutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, lumbar; first level. |
| 0629T | Percutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, lumbar; each additional level. |
| 0630T | Percutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, lumbar; each additional level (List separately). |
| C2614 | Probe, percutaneous lumbar discectomy. |
| G0276 | Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (PILD) or placebo-control, performed in an approved coverage with evidence development (CED) clinical trial. |
| S2348 | Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, using radiofrequency energy, single or multiple levels, lumbar. |
| M43.12-M43.17 | Spondylolisthesis (code range). |
| M48.02-M48.07 | Spinal stenosis (code range). |
| M50.20-M50.23 | Other cervical disc displacement (code range). |
| M50.33 | |
| M51.06 | Intervertebral disc disorders with myelopathy, lumbar region. |
| M51.16 | Intervertebral disc disorders with radiculopathy, lumbar. |
| M51.17 | |
| M51.24- | |
| M51.27 | |
| M51.34- | Other intervertebral disc degeneration (code range). |
| C2614 | Probe, percutaneous lumbar discectomy |
| G0276 | Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (PILD) or placebo-control, performed in an approved CED clinical trial |
| S2348 | Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, using radiofrequency energy, single or multiple levels, lumbar |
| M43.12-M43.17 | Spondylolisthesis (code range) |
| M48.02-M48.07 | Spinal stenosis (code range) |
| M50.20-M50.23 | Other cervical disc displacement (code range) |
| M50.33 | |
| M51.06 | Intervertebral disc disorders with myelopathy, lumbar region |
| M51.16 | Intervertebral disc disorders with radiculopathy, lumbar |
| M51.17 | |
| M51.24 | |
| M51.27 | |
| M51.34 | Other intervertebral disc degeneration (code range) |
Provider Actions — Authorization, Documentation, and Denial Risk
Prior authorization governed by Univera policy
Prior authorization for intradiscal procedures is governed by Univera Healthcare medical policy determinations; intradiscal procedures listed as investigational are not supported as medically necessary and are subject to PA requirements per the payer.
- Submit clinical rationale and device details when requesting PA
PA implied for device‑specific intradiscal techniques
Prior authorization is implied for intradiscal procedures given the variety of device‑specific techniques and their investigational status; providers should submit clinical rationale and device/technique details with PA requests.
- Include procedure type, device model (e.g., Dekompressor, Nucleotome, SpineJet) and intended mechanism in PA submissions
PA may be required for E/I‑coded intradiscal procedures
Procedures represented by the listed CPT and HCPCS codes are designated Experimental/Investigational (E/I) and may require prior authorization or be subject to coverage determination.
Document conservative management and surgical referral rationale
Document prior conservative care and the rationale for choosing an intradiscal intervention, including why standard surgical discectomy or other conventional pathways are not appropriate for this patient.
- Record prior nonoperative treatments and objective reasons for referral to intradiscal procedure
- If applicable, document why standard surgical discectomy was not selected or is contraindicated
Document failure of conservative therapy prior to intervention
Evidence summaries indicate that patients enrolled in key trials generally had failed conservative therapy; providers should document failure of conservative management before intradiscal interventions when applicable.
- Document specific conservative therapies tried and duration (e.g., ESIs, physical therapy)
Basis for medical necessity documentation
Medical necessity determinations are based on evidence‑based literature, national guidelines, federal/state law, and the member's subscriber contract; include citations or guideline references in PA/documentation when relevant.
- Reference applicable guideline or evidence when submitting PA or appeals
Required procedure documentation elements
Documentation for intradiscal procedures must include the procedure type, targeted disc level(s), device used (when applicable), and the image guidance method (fluoroscopy or endoscopic visualization).
- Specify single vs. multilevel (and list additional level codes if applicable)
- Indicate image guidance method used (fluoroscopy, CT, or endoscopic visualization)
Include device regulatory status in documentation
FDA 510(k) clearance or regulatory status for specific intradiscal devices is noted in the policy and may be relevant to documentation of device use (e.g., Dekompressor, Nucleotome, SpineJet, Baylis devices); include device regulatory information when available.
- List device name and FDA status in the clinical record or PA submission
Check product‑specific applicability and contract coverage
Coverage and PA requirements may vary by product: if a Medicare/Medicaid product covers the service, medical policy criteria apply unless there is a national/local Medicare or NY Medicaid guideline; if a product does not cover the service, policy criteria do not apply.
- Check member’s product benefit and local Medicare/Medicaid guidance before submitting PA
Denial risk for investigational intradiscal procedures
Claims for intradiscal procedures listed as investigational are subject to denial as investigational/not medically necessary; submitting required documentation does not guarantee coverage.
- Denials may result when procedures are designated investigational in the policy
Non‑coverage risk for procedures with limited/conflicting evidence (e.g., APD)
Procedures with limited or conflicting evidence (for example APD) have been associated with poorer or inconsistent outcomes and may be judged investigational or not medically necessary, increasing risk of non‑coverage.
- APD trials and systematic reviews reported inferior or conflicting outcomes compared with standard discectomy
Coverage risk associated with E/I or NMN procedure codes
Codes designated E/I or NMN in this policy may not be covered and use of those CPT/HCPCS codes could trigger denials or additional review; providers should verify code coverage and obtain PA when indicated.
Verify contract/product coverage before performing procedure
Services are contract dependent; if a product does not cover a service, medical policy criteria do not apply — confirm member benefit and coverage prior to scheduling procedures.
- Verify commercial/Medicaid/Medicare product coverage and apply local guidance (eMedNY or national/local Medicare) as required
Background and Scope
Background: This policy evaluates a range of intradiscal procedures used to treat disc‑related spinal pain by assessing peer‑reviewed literature and professional guideline statements. The document summarizes mechanisms, device examples, and clinical trial evidence for techniques such as automated percutaneous discectomy, endoscopic methods, IDET/IDTA, PIRFT, intradiscal biacuplasty, nucleoplasty, and laser discectomy, and it uses randomized trials, systematic reviews, and guideline conclusions to inform coverage stance.
Definitions — Procedure Descriptions
Conservative Treatment Requirements
Document prior conservative care and rationale for intradiscal procedure
Document prior conservative care and rationale for intradiscal procedure
Policy references expectation that conservative management and surgical referral pathways be documented prior to intradiscal interventions.
Evidence summaries (e.g., MILD trial) imply enrollment after failed conservative therapy.
Failure of conservative therapy is implied though not exhaustively defined
Failure of conservative therapy is implied though not exhaustively defined
Policy evidence sections describe trial populations that had failed conservative therapy but do not specify exact pre-procedure thresholds.
Policy emphasizes appropriate patient selection and documentation; does not define exhaustive criteria.
Frequency and Procedural Details
Imaging and Guidance Requirements
Imaging requirements not specified in excerpt
The policy bases coverage on clinical evidence and guidelines; specific imaging requirements are not provided in this excerpt.
Fluoroscopy or endoscopic visualization required for APD, endoscopic discectomy, IDET/IDTA
For APD, endoscopic discectomy, and intradiscal electrothermal annuloplasty (IDET/IDTA), procedures are performed under fluoroscopic guidance or with endoscopic visualization and documentation should reflect the image guidance used.
- Document fluoroscopy or endoscopic visualization used during the procedure.
Fluoroscopy or CT image guidance for percutaneous decompression and injections
CPT descriptions for percutaneous decompression, intradiscal injections, and percutaneous laminotomy/laminectomy reference fluoroscopic or CT image guidance; document the type of image guidance used when applicable.
- Specify fluoroscopy or CT guidance in operative and billing records when using codes that reference imaging guidance.
PILD (G0276) is image‑guided—document image guidance
The HCPCS code G0276 references percutaneous image‑guided lumbar decompression (PILD), indicating the procedure is image‑guided; document image guidance when billing this service.
- When billing G0276, indicate the image‑guided PILD technique and any trial/CED context if applicable.
Not Covered Procedures
Not covered: The policy enumerates specific intradiscal procedures that are considered not covered or investigational, including Annulo‑nucleoplasty (Disc‑FX), Cervical intradiscal radiofrequency lesioning, and Coblation percutaneous disc decompression. HCPCS codes referenced in the policy (e.g., C2614, G0276, S2348) are similarly listed as experimental/investigational.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.